THE DEAL, AT A GLANCE
From the announcementEvotec
01Who is involvedBacked by Novo HoldingsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedEvotec raised $200M Growth RoundFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersEvotec is using Growth Round capital to scale AI-driven drug discovery capacity and expand its CNS disease platform, supported by an existing partnership base across…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Evotec · Financing Record
Explore source-linked visual explanations for Evotec. Unsupported claims are withheld while source review continues.
Record 465 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →